Legal Representation
Attorney
Melissa E. Scott
USPTO Deadlines
Next Deadline
1891 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-09-24)
Due Date
September 24, 2030
Grace Period Ends
March 24, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
21 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Mar 12, 2025 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
Sep 24, 2024 | NRCS | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
Sep 24, 2024 | R.SR | A | REGISTERED-SUPPLEMENTAL REGISTER | Loading... |
Aug 19, 2024 | CNTA | O | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | Loading... |
Aug 16, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Aug 16, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Aug 16, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Aug 16, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
Jul 11, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Jul 11, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Jul 11, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Jul 8, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Jul 8, 2024 | IUAA | P | USE AMENDMENT ACCEPTED | Loading... |
Jul 8, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Jul 8, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Jun 26, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Feb 28, 2024 | AUPC | I | AMENDMENT TO USE PROCESSING COMPLETE | Loading... |
Feb 28, 2024 | EAAU | I | TEAS AMENDMENT OF USE RECEIVED | Loading... |
Feb 28, 2024 | IUAF | S | USE AMENDMENT FILED | Loading... |
Jan 17, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Nov 30, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Promoting public awareness of clinical trial results, namely, reporting and presentation of clinical trial results; Providing consulting services in the field of regulatory submission management to medical, biopharmaceutical and biotechnology companies to assist them with the submission of clinical trial results for applications for new pharmaceuticals and medical devices with governmental regulatory bodies; Regulatory submission management, namely, responding to inquiries regarding clinical trials from governmental regulatory bodies; Customer services, namely, responding to participant inquiries regarding clinical trials
First Use Anywhere:
Sep 21, 1988
First Use in Commerce:
Mar 3, 1999
Class 042
Consulting services for others in the field of guidance on the design of clinical trials; Consulting services for others in the field of expert review of proposed clinical trial design; data analysis of clinical trial results and clinical trial application submissions for others
First Use Anywhere:
Sep 21, 1988
First Use in Commerce:
Mar 3, 1999
Class 045
Representation of clients in biomedical and pharmaceutical regulatory proceedings
First Use Anywhere:
Sep 21, 1988
First Use in Commerce:
Mar 3, 1999
Classification
International Classes
035
042
045
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
CONSULTING